ÂÜÀòÂÒÂ×

David McErlane is an experienced leader in the biopharmaceutical industry currently serving as the Group President of Biologics at Catalent Pharma Solutions since September 2023. McErlane previously held senior roles at Lonza, including Senior Vice President & Business Unit Head for Bioscience, where leadership encompassed a diverse portfolio supporting drug discovery and development. Further responsibilities included overseeing global operations and multiple production sites, managing a workforce exceeding 700 personnel across various regions. Prior positions at MilliporeSigma and BioReliance involved strategic leadership in global testing operations and biomanufacturing. With a strong engineering background developed at companies including Zeneca and ICI Paints, and academic credentials from Glasgow Caledonian University and Cranfield School of Management, McErlane’s extensive expertise spans operations, validation, and strategic development across the life sciences sector.